These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 18202727)

  • 1. [Usefulness of HPV test on cell sample from the cervix].
    Vintermyr OK; Skar R; Iversen OE; Haugland HK
    Tidsskr Nor Laegeforen; 2008 Jan; 128(2):171-3. PubMed ID: 18202727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resolution of equivocal results with the Hybrid Capture II high-risk HPV DNA test: a cytologic/histologic review of 191 cases.
    Knoepp SM; Kuebler DL; Wilbur DC
    Diagn Mol Pathol; 2007 Sep; 16(3):125-9. PubMed ID: 17721319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HPV mRNA test in women with minor cervical lesions: experience of the University Hospital of North Norway.
    Sorbye SW; Fismen S; Gutteberg TJ; Mortensen ES
    J Virol Methods; 2010 Oct; 169(1):219-22. PubMed ID: 20638416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of HPV testing in patients with possible high-grade cervical cytology.
    Rao A; Pather S; Dalrymple C; Mackie A; Deans R; Carter J
    J Obstet Gynaecol Res; 2009 Jun; 35(3):503-6. PubMed ID: 19527390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular testing of human papillomavirus in cervical specimens.
    Gazzaz FB
    Saudi Med J; 2007 Dec; 28(12):1810-8. PubMed ID: 18060207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1.
    Jordan J; Arbyn M; Martin-Hirsch P; Schenck U; Baldauf JJ; Da Silva D; Anttila A; Nieminen P; Prendiville W
    Cytopathology; 2008 Dec; 19(6):342-54. PubMed ID: 19040546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of HPV 16 PCR detection in self- compared with clinician-collected samples in women referred for colposcopy.
    Daponte A; Pournaras S; Mademtzis I; Hadjichristodoulou C; Kostopoulou E; Maniatis AN; Messinis IE
    Gynecol Oncol; 2006 Nov; 103(2):463-6. PubMed ID: 16626791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of high-grade cervical dysplasia by the detection of p16INK4a in cell lysates obtained from cervical samples.
    Wentzensen N; Hampl M; Herkert M; Reichert A; Trunk MJ; Poremba C; Ridder R; von Knebel Doeberitz M
    Cancer; 2006 Nov; 107(9):2307-13. PubMed ID: 17029280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subvisual chromatin changes in cervical epithelium measured by texture image analysis and correlated with HPV.
    Guillaud M; Adler-Storthz K; Malpica A; Staerkel G; Matisic J; Van Niekirk D; Cox D; Poulin N; Follen M; Macaulay C
    Gynecol Oncol; 2005 Dec; 99(3 Suppl 1):S16-23. PubMed ID: 16188299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Verrucous carcinoma of the cervix: detection of carcinogenetic human papillomavirus types and their role during follow-up.
    Frega A; Lukic A; Nobili F; Palazzo A; Iacovelli R; French D; Moscarini M
    Anticancer Res; 2007; 27(6C):4491-4. PubMed ID: 18214065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and type distribution of high-risk human papillomavirus infection in women undergoing voluntary cervical cancer screening in Italy.
    Agarossi A; Ferrazzi E; Parazzini F; Perno CF; Ghisoni L
    J Med Virol; 2009 Mar; 81(3):529-35. PubMed ID: 19152401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Research of the relationship between cervical cytology and HPV test and lesions in the cervical tissue].
    Zhang LD; Xie W; Pei J; Zhao D
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Aug; 26(4):276-8. PubMed ID: 23189843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The New Technologies for Cervical Cancer Screening randomised controlled trial. An overview of results during the first phase of recruitment.
    Ronco G; Brezzi S; Carozzi F; Dalla Palma P; Giorgi-Rossi P; Minucci D; Naldoni C; Segnan N; Zappa M; Zorzi M; Cuzick J;
    Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S230-2. PubMed ID: 17822751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ASC-US and high-risk HPV testing: performance in daily clinical practice.
    Selvaggi SM
    Diagn Cytopathol; 2006 Nov; 34(11):731-3. PubMed ID: 17041955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection and typing of human papilloma virus by polymerase chain reaction and hybridization assay in cervical samples with cytological abnormalities].
    Ergünay K; Misirlioğlu M; Firat P; Tuncer ZS; Tuncer S; Yildiz I; Ustaçelebi S
    Mikrobiyol Bul; 2008 Apr; 42(2):273-82. PubMed ID: 18697425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of high-risk human papillomavirus type 16/18 infection among women with normal cytology: risk factor analysis and implications for screening and prophylaxis.
    Gupta S; Sodhani P; Sharma A; Sharma JK; Halder K; Charchra KL; Sardana S; Singh V; Sehgal A; Das BC
    Cytopathology; 2009 Aug; 20(4):249-55. PubMed ID: 19018810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A peer comparison program for the quality assurance of human papillomavirus DNA detection using the Digene Hybrid Capture II/SurePath method shows excellent analytic interlaboratory correlation.
    Kuebler DL; Illingworth A; Blenc AM; Wilbur DC
    Cancer; 2007 Oct; 111(5):339-43. PubMed ID: 17879373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjunctive high-risk human papillomavirus DNA testing is a useful option for disease risk assessment in patients with negative Papanicolaou tests without an endocervical/transformation zone sample.
    Zhao C; Austin RM
    Cancer; 2008 Aug; 114(4):242-8. PubMed ID: 18484643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficiency of the APTIMA HPV Assay for detection of HPV RNA and DNA targets.
    Getman D; Aiyer A; Dockter J; Giachetti C; Zhang F; Ginocchio CC
    J Clin Virol; 2009 Jul; 45 Suppl 1():S49-54. PubMed ID: 19651369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-grade cervical abnormalities and screening intervals in New South Wales, Australia.
    Schindeler S; Morrell S; Zuo Y; Baker D
    J Med Screen; 2008; 15(1):36-43. PubMed ID: 18416954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.